Huili Pharmaceutical

Huili Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company is particularly recognized for its expertise in cephalosporin and penicillin-based antibiotics, producing key products such as Cefixime and Cefdinir. With multiple GMP-certified production facilities, Huili serves both domestic and international markets, providing high-quality chemical synthesis services. Their business model focuses on vertical integration within the anti-infective therapeutic area, supporting global pharmaceutical supply chains. The company maintains a strong focus on quality control and regulatory compliance to meet international standards for pharmaceutical exports.